시장보고서
상품코드
1663542

관류 영상 진단 시장 : 어세이 유형별, 모달리티별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율, 예측(2025-2032년)

Perfusion Radiology Market, By Assay Type, By Modality, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 269 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

관류 영상 진단(관류 방사선학) 시장 규모는 2024년 28억 1,420만 달러로 평가되었고, 2025-2032년간 연평균 4.50% 성장할 것으로 예상됩니다.

관류 영상 진단 시장 역학

심혈관 및 신경 질환 증가

생활습관의 변화와 식습관의 변화로 인한 심혈관 질환과 신경 질환 증가로 관류 영상 진단 시장이 확대되고 있습니다. 뇌졸중 통계 소위원회와 미국심장협회 통계위원회가 발표한 통계에 따르면, 연간 795,000명이 심장마비를 앓고 있으며, 2017년에는 이 수치가 발표되었습니다. 따라서 정부 주도 이니셔티브, 의료 시설 및 기타 조직은 진행 상황을 모니터링하고 질병을 치료하는 데 도움이 되는 기술 개발에 대한 지식을 높이기 위한 전략을 서둘러 마련해야 합니다. 관류 영상은 장기의 혈류를 측정하는 정확한 영상 진단 방법을 사용하여 의사가 이상을 발견하고, 질병의 경과를 추적하고, 치료의 효과를 측정하는 데 도움이 됩니다. 관류 영상 진단의 채택은 복잡한 신경계 및 심혈관계 질환을 치료하기 위한 정확하고 비침습적인 진단 기술에 대한 요구가 증가함에 따라 기술 혁신과 시장 확대가 촉진되고 있습니다.

관류 영상 진단 시장 : 주요 고려사항

당사의 리서치 애널리스트들의 분석에 따르면, 세계 시장은 예측 기간(2025-2032년) 동안 연평균 약 4.50%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.

분석 유형별로는 심혈관 영상진단이 2024년 가장 큰 시장 점유율을 보였습니다..

최종 용도별로는 2024년 병원이 주요 부문으로 꼽혔습니다.

지역별로는 북미가 2024년 수익을 창출한 주요 시장입니다.

관류 영상진단 시장 : 세분화 분석

세계 관류 영상 진단 시장은 분석 유형, 양식, 최종 용도, 지역에 따라 세분화됩니다.

분석 유형에 따라 시장은 심혈관 영상, 뇌 영상, 관류 영상으로 분류되며, 2024년에는 심혈관 질환(CVD)이 전 세계적으로 점점 더 흔해짐에 따라 심혈관 영상 카테고리가 시장을 지배할 것으로 예상됩니다. 컴퓨터 단층촬영(CT) 및 자기공명영상(MRI)과 같은 영상기술의 발달로 관류 영상진단은 심장질환을 식별하고 치료하는 데 더욱 정확하고 효과적일 수 있게 되었습니다. 또한, 의료비 상승과 조기 진단 및 치료에 대한 인식이 높아짐에 따라 심혈관 영상 진단 기술에 대한 수요가 증가하고 있습니다. 인공지능(AI)의 접목으로 진단 정확도가 더욱 향상됨에 따라 영상 진단 시스템은 임상 진료에 필수적인 요소로 자리 잡고 있습니다.

2024년에는 자기공명영상(MRI), 핵의학, 컴퓨터단층촬영(CT)으로 구분되며, 컴퓨터단층촬영(CT) 부문이 광범위한 가용성, 우수한 진단 정확도, 종합적인 단면 영상을 제공하는 능력으로 인해 압도적인 시장 점유율을 차지할 것으로 예상됩니다. CT는 뇌졸중 관리 및 뇌혈류 평가에 필수적이며, 저선량 CT 등의 개발로 인해 그 활용도가 높아지고 있습니다. 종양학, 신경학, 심혈관 치료에는 동맥 스핀라벨(ASL) 및 동적 조영(DCE) 영상과 같은 기술이 널리 활용되고 있습니다. 자기공명영상(MRI)은 우수한 연부조직 대비, 비침습적 기능, 방사선을 사용하지 않는 영상 진단으로 인해 점점 더 널리 사용되고 있습니다.

관류영상진단 시장 : 지역별 분석

2024년 북미는 관류 영상 진단 세계 시장에서 압도적인 위치를 차지할 것으로 예상됩니다. 이러한 리더십은 이 지역의 의학 연구에 대한 강력한 투자, 신경 및 심혈관 질환의 높은 유병률, 잘 구축된 의료 인프라에 기인합니다. 미국은 지멘스, 제너럴 일렉트릭과 같은 시장 진출기업이 집중되어 있고, 첨단 영상 기술을 적극적으로 도입하고 있어 이 지역의 성장을 주도하고 있습니다. 유리한 상환 규정이 이 지역의 관류 영상 진단 시장의 성장을 더욱 촉진하고 있습니다.

그러나 예측 기간 동안 가장 빠른 CAGR을 보일 지역은 유럽입니다. 독일, 프랑스, 영국은 정교한 의료 시스템, 첨단 기술의 보급, 질병의 조기 발견을 장려하는 정부 프로그램으로 시장을 선도하고 있습니다. 유럽의 고령화와 암, 뇌졸중과 같은 만성 질환의 유병률이 증가함에 따라 관류 영상 진단 기술은 점점 더 많은 수요가 증가하고 있습니다. 유럽연합(EU)의 의학 연구 촉진 노력과 국제 의료 파트너십은 관류 영상 진단 시장 확대에 박차를 가하고 있습니다.

관류 영상 진단 시장 : 경쟁 구도

GENERAL ELECTRIC COMPANY, Siemens Healthineers AG, Sonic Healthcare, InHealth Group, RadNet, Inc. 등 경쟁이 치열한 관류 영상 진단 시장에서 여러 경쟁자들이 더 큰 점유율을 차지하기 위해 경쟁하고 있습니다. 제약회사, 소프트웨어 솔루션 제공업체, 의료용 영상기기 제조업체도 중요한 업계 참여 기업입니다. 이들 기업은 시장 지위를 향상시키기 위해 연구개발, 전략적 제휴, M&A, 신제품 도입에 주력하고 있습니다. 제품 포트폴리오, 기술 개발, 고객 서비스, 가격 정책, 브랜드 평판은 시장 경쟁력을 결정하는 중요한 요소입니다. 의료 제공업체의 고유 한 요구 사항을 충족하고 환자 치료를 개선하며 전반적인 운영 효율성을 높이기 위해 시장 진출기업은 종합적인 관류 영상 진단 솔루션을 제공하기 위해 노력하고 있습니다. 예를 들어, 2023년 5월 스페인에서 개최된 European Association of Cardiovascular Imaging(EACVI) 회의에서 Ion Beam Applications S.A.에서 PET 심근 관류 기반 영상진단을 위한 희귀한 EURONEXT 회원사인 IBA는 방사성의약품 제조 솔루션 및 입자 가속기 기술 개발의 선두주자이며, 이번 회의에서 이 첨단 기술을 소개하였습니다.

목차

제1장 관류 영상 진단 시장 개요

  • 조사 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 관류 영상 진단 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 향후 동향

제4장 관류 영상 진단 시장 : 산업 분석

  • PEST 분석
  • Porter의 Five Forces 분석
  • 시장 성장 전망 : 맵핑
  • 규제 체제 분석

제5장 관류 영상 진단 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 관류 영상 진단 시장 구도

  • 관류 영상 진단 시장 점유율 분석(2024년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제7장 관류 영상 진단 시장 : 어세이 유형별

  • 개요
    • 부문별 점유율 분석 : 어세이 유형별
    • 심혈관 영상 진단
    • 뇌 영상 진단
    • 환기 영상 진단

제8장 관류 영상 진단 시장 : 모달리티별

  • 개요
    • 부문별 점유율 분석 : 모달리티별
    • 자기공명영상(MRI)
    • 핵의학
    • 컴퓨터단층촬영(CT)

제9장 관류 영상 진단 시장 : 최종 용도별

  • 개요
    • 부문별 점유율 분석 : 최종 용도별
    • 병원
    • 진료소
    • 진단실험실
    • 기타

제10장 관류 영상 진단 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 영국
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 한국
    • 일본
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 관류 영상 진단 업계

  • 경쟁 대시보드
  • 기업 개요
    • GENERAL ELECTRIC COMPANY
    • Siemens Healthineers AG
    • Sonic Healthcare
    • InHealth Group
    • RadNet, Inc.
    • Spectrum Health
    • Alliance HealthCare Services
    • Hologic Inc.
    • Koninklijke Philips NV
    • RamSoft, Inc.
    • Others

제12장 AnalystView의 전방위적 분석

LSH 25.03.18

REPORT HIGHLIGHT

Perfusion Radiology Market size was valued at US$ 2,814.2 Million in 2024, expanding at a CAGR of 4.50% from 2025 to 2032.

Perfusion radiology is the study of blood flow patterns in particular bodily parts, organs, or tissues. It entails giving contrast agents, which improve blood vessel visibility and make it easier to see blood flow in real-time. Perfusion radiology allows radiologists to evaluate tissue viability, spot regions of decreased or increased blood flow, and spot anomalies. This diagnostic method is non-invasive and essential for offering important information about how different organs work physiologically. The growing prevalence of chronic diseases, the need for precise diagnostic methods, and improvements in imaging technology are all contributing to the significant rise of the global perfusion radiology market. New software programs and imaging modalities that improve the precision and effectiveness of perfusion radiology procedures are being introduced to the market. Furthermore, the market is expanding due to rising patient and healthcare professional awareness of the advantages of perfusion radiology. Nonetheless, various obstacles, like the high cost of equipment and restricted accessibility in underdeveloped nations, can somewhat impede the perfusion radiology market expansion.

Perfusion Radiology Market- Market Dynamics

Increase in cardiovascular and neurological conditions

The market for perfusion radiology is growing as a result of an increase in cardiovascular and neurological conditions brought on by altered lifestyles and poor eating habits. According to statistics issued by the Stroke Statistics Subcommittee and the American Heart Association Statistics Committee, 795,000 persons have a heart attack annually. In 2017, these figures were made public. Government-funded initiatives, medical facilities, and other organizations must, therefore, immediately devise strategies to raise knowledge of the technological developments that aid in monitoring progress and curing the illness. By using accurate imaging methods to measure organ blood flow, perfusion radiology helps doctors spot anomalies, track the course of diseases, and gauge how well treatments are working. Perfusion radiology adoption is being fueled by the increasing need for precise and non-invasive diagnostic techniques to treat complicated neurological and cardiovascular problems, which is propelling innovation and market expansion.

Perfusion Radiology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2025-2032)

Based on assay type segmentation, cardiovascular imaging was predicted to show maximum market share in the year 2024

Based on end-use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Perfusion Radiology Market- Segmentation Analysis:

The Global Perfusion Radiology Market is segmented on the basis of Assay Type, Modality, End Use, and Region.

On the basis of assay type, the market is segregated into Cardiovascular Imaging, Brain Imaging, and Ventilation Imaging. In 2024, the market was dominated by the cardiovascular imaging category because cardiovascular diseases (CVDs) are becoming more and more common worldwide. Perfusion radiology has become more accurate and effective in identifying and treating cardiac problems due to developments in imaging technologies like computed tomography (CT) and magnetic resonance imaging (MRI). Furthermore, the need for cardiovascular imaging technologies has been fueled by rising healthcare costs as well as increased awareness of early diagnosis and treatment. Imaging systems have become essential in clinical practice due to the further improvement in diagnostic precision brought about by the incorporation of artificial intelligence (AI).

Based on modality, the market is divided into Magnetic Resonance Imaging (MRI), Nuclear Medicine, and Computed Tomography (CT). In 2024, the computed tomography (CT) category held a dominant market share because of its extensive availability, excellent diagnostic precision, and capacity to provide comprehensive cross-sectional images. They are crucial for managing strokes and evaluating cerebral blood flow, and developments such as low-dose CT are encouraging their use. Oncology, neurology, and cardiovascular care all make extensive use of techniques like arterial spin labelling (ASL) and dynamic contrast-enhanced (DCE) imaging. Magnetic resonance imaging (MRI) is becoming more and more popular due to its superior soft-tissue contrast, non-invasive capabilities, and radiation-free imaging.

Perfusion Radiology Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Perfusion Radiology. This leadership is ascribed to the region's strong investments in medical research, high prevalence of neurological and cardiovascular disorders, and well-established healthcare infrastructure. The United States primarily drives regional growth because of its large concentration of major market participants like Siemens and General Electric, as well as its robust adoption of advanced imaging technologies. Favourable reimbursement regulations further aid the growth of the perfusion radiology market in this area.

However, throughout the projected period, the Europe region is anticipated to see the fastest CAGR. Germany, France, and the UK are leading the way because of their sophisticated healthcare systems, widespread use of cutting-edge technologies, and government programs that encourage early disease detection. Perfusion radiology technologies are becoming more and more in demand as Europe's ageing population and the prevalence of chronic illnesses like cancer and stroke rise. The European Union's initiatives to promote medical research and international healthcare partnerships help fuel the perfusion radiology market expansion.

Perfusion Radiology Market- Competitive Landscape:

Several competitors are fighting for a larger share in the very competitive perfusion radiology market, such as GENERAL ELECTRIC COMPANY, Siemens Healthineers AG, Sonic Healthcare, InHealth Group, RadNet, Inc., and others. Pharmaceutical firms, software solution providers, and makers of medical imaging equipment are important industry participants. To improve their market position, these businesses concentrate on R&D, strategic alliances, mergers and acquisitions, and new product introductions. Product portfolio, technology developments, customer service, price policies, and brand reputation are important determinants of market competitiveness. In order to meet the unique requirements of healthcare providers, improve patient care, and increase overall operational efficiency, market participants work hard to deliver comprehensive perfusion radiology solutions. For instance, in May 2023, an unusual combination solution for PET myocardial perfusion-based imaging, AKURACY, was introduced by the Ion Beam Applications S.A. During the meeting of the European Association of Cardiovascular Imaging (EACVI) in Spain, this advanced technology was introduced. IBA, which is a member of EURONEXT, is a leader in the development of radiopharmaceutical production solutions and particle accelerator technologies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERFUSION RADIOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GENERAL ELECTRIC COMPANY
  • Siemens Healthineers AG
  • Sonic Healthcare
  • InHealth Group
  • RadNet, Inc.
  • Spectrum Health
  • Alliance HealthCare Services
  • Hologic Inc.
  • Koninklijke Philips N.V.
  • RamSoft, Inc.
  • Others

GLOBAL PERFUSION RADIOLOGY MARKET, BY ASSAY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular Imaging
  • Brain Imaging
  • Ventilation Imaging

GLOBAL PERFUSION RADIOLOGY MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Magnetic Resonance Imaging (MRI)
  • Nuclear Medicine
  • Computed Tomography (CT)

GLOBAL PERFUSION RADIOLOGY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Others

GLOBAL PERFUSION RADIOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Perfusion Radiology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Perfusion Radiology Market Snippet by Assay Type
    • 2.1.2. Perfusion Radiology Market Snippet by Modality
    • 2.1.3. Perfusion Radiology Market Snippet by End Use
    • 2.1.4. Perfusion Radiology Market Snippet by Country
    • 2.1.5. Perfusion Radiology Market Snippet by Region
  • 2.2. Competitive Insights

3. Perfusion Radiology Key Market Trends

  • 3.1. Perfusion Radiology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Perfusion Radiology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Perfusion Radiology Market Opportunities
  • 3.4. Perfusion Radiology Market Future Trends

4. Perfusion Radiology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Perfusion Radiology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Perfusion Radiology Market Landscape

  • 6.1. Perfusion Radiology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Perfusion Radiology Market - By Assay Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Assay Type, 2024 & 2032 (%)
    • 7.1.2. Cardiovascular Imaging
    • 7.1.3. Brain Imaging
    • 7.1.4. Ventilation Imaging

8. Perfusion Radiology Market - By Modality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
    • 8.1.2. Magnetic Resonance Imaging (MRI)
    • 8.1.3. Nuclear Medicine
    • 8.1.4. Computed Tomography (CT)

9. Perfusion Radiology Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Diagnostic Laboratories
    • 9.1.5. Others

10. Perfusion Radiology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Perfusion Radiology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Perfusion Radiology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Perfusion Radiology Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Perfusion Radiology Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Perfusion Radiology Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Perfusion Radiology Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. GENERAL ELECTRIC COMPANY
    • 11.2.2. Siemens Healthineers AG
    • 11.2.3. Sonic Healthcare
    • 11.2.4. InHealth Group
    • 11.2.5. RadNet, Inc.
    • 11.2.6. Spectrum Health
    • 11.2.7. Alliance HealthCare Services
    • 11.2.8. Hologic Inc.
    • 11.2.9. Koninklijke Philips N.V.
    • 11.2.10. RamSoft, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제